Radionetics Oncology
Signal active
Organization
Contact Information
Overview
Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications.
About
Industries
Health Care, Pharmaceutical, Medical, Therapeutics, Oncology
Founded
2021
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Radionetics Oncology headquartered in United States, North America, operates in the Health Care, Pharmaceutical, Medical, Therapeutics, Oncology sector. The company focuses on Health Care and has secured $8.1B in funding across 60 round(s). With a team of 11-50 employees, Radionetics Oncology is actively contributing to advancements in Health Care. Their latest funding round, Series A - Radionetics Oncology, raised $52.5M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
5
Lead Investors
0
Total Funding Amount
$135.0M
Details
3
Radionetics Oncology has raised a total of $135.0M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Seed | 30.0M | ||
| 2023 | Early Stage Venture | 52.5M | ||
| 2024 | Early Stage Venture | 52.5M |
Investors
Radionetics Oncology is funded by 15 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| 5AM Ventures | - | FUNDING ROUND - 5AM Ventures | 52.5M |
| DCVC Bio | - | FUNDING ROUND - DCVC Bio | 52.5M |
| Radionetics Oncology | - | FUNDING ROUND - Radionetics Oncology | 52.5M |
| Crinetics Pharmaceuticals | - | FUNDING ROUND - Crinetics Pharmaceuticals | 52.5M |
Recent Activity
There is no recent news or activity for this profile.